Compare Bio Protocol (BIO) vs Yei Finance (Clovis) (CLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Yei Finance (Clovis) — how do they compare? Bio Protocol trades at Rp432.76 (market cap Rp983,55M, Rp163,9M 24h volume), while Yei Finance (Clovis) trades at Rp2,057 (market cap Rp266,05M, Rp40,83M 24h volume). The key difference: Bio Protocol is far larger — about 3.7× Yei Finance (Clovis)'s market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 129,1M / 1B CLO (13%) for Yei Finance (Clovis). Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Yei Finance (Clovis) for 3 Days on average.
| BIO | CLO | |
|---|---|---|
Market Cap | Rp983,55M | Rp266,05M |
Volume (24h) | Rp163,9M | Rp40,83M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 129,1M / 1B CLO (13%) |
Typical Hold Time | 18 Days | 3 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Yei Finance (CLO) is currently trading at Rp2,048 with a bearish technical outlook as all 16 moving average signals indicate selling pressure. The token shows limited circulation at 13% of max supply and extremely short average hold time of 3 days. Current price sits near the pivot point of Rp2,022 with resistance at Rp2,174 and support at Rp1,900.
Overall outlook remains cautious due to weak technical indicators and low adoption metrics. Key opportunity lies in potential oversold bounce from support levels, while major risks include low liquidity, minimal network activity, and high volatility from concentrated holdings.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Yei Finance (Clovis)
Yei Finance (Clovis) is a liquidity abstraction layer designed to reunify fragmented capital across networks. It integrates cross-chain DEX, money markets, and bridging to provide on-demand global liquidity for multiple assets and chains. Its architecture enables liquidity providers to earn diversified yields while offering users near-instant cross-network transfers.
Read more on CLO →
